Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06916702
PHASE1

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3031185 in healthy male subjects following administration of multiple rising doses.

Official title: Safety, Tolerability, and Pharmacokinetics of Multiple Rising Oral Doses of BI 3031185 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design)

Key Details

Gender

MALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-04-07

Completion Date

2026-11-02

Last Updated

2026-02-17

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

BI 3031185

BI 3031185

DRUG

Midazolam

Midazolam

DRUG

Placebo

Placebo matching BI 3031185

Locations (1)

Charité Research Organisation GmbH

Berlin, Germany